Opening Conference | Building Safer AI for Youth Mental Health
On March 16, join leading AI researchers, clinical experts, and voices from the ground for an event exploring the frameworks needed to design AI that is not only powerful, but also safe for mental health.
TRAIL: Responsible AI for Professionals and Leaders
Learn how to integrate responsible AI practices into your organization with TRAIL. Join our information session on March 12, where you’ll discover the program in detail and have the chance to ask all your questions.
We use cookies to analyze the browsing and usage of our website and to personalize your experience. You can disable these technologies at any time, but this may limit certain functionalities of the site. Read our Privacy Policy for more information.
Setting cookies
You can enable and disable the types of cookies you wish to accept. However certain choices you make could affect the services offered on our sites (e.g. suggestions, personalised ads, etc.).
Essential cookies
These cookies are necessary for the operation of the site and cannot be deactivated. (Still active)
Analytics cookies
Do you accept the use of cookies to measure the audience of our sites?
Multimedia Player
Do you accept the use of cookies to display and allow you to watch the video content hosted by our partners (YouTube, etc.)?
Cognitive deficits are common across many neurodevelopmental and psychiatric conditions, including those studied in the current set of PGC-C… (see more)NV papers. How changes in regional gene expression across the cerebral cortex influence cognitive ability remains unknown. Population variation in gene dosage—which significantly impacts gene expression—represents a unique paradigm to address this question. We developed a cerebral-cortex gene-set burden analysis (CC-GSBA) to associate a trait with genomic deletions and duplications that disrupt genes with similar expression profiles across 180 cortical regions. We performed CC-GSBA across 180 cortical regions to test associations with cognitive ability in 260,000 individuals from general population cohorts. Most cortical gene sets were associated with a decrease in cognitive ability when deleted or duplicated, and this novel approach revealed opposing cortical patterns for the effect sizes of deletions and duplications. These cortical patterns of effect sizes followed the cortical gradient previously characterized at the molecular, cellular, and functional levels. We show that genes with preferential expression in sensorimotor regions demonstrated the largest effect on cognition when deleted. At the opposing end of the cortical gradient, genes with preferential expression in multimodal association regions affected cognition the most when duplicated. These two gene dosage cortical patterns could not be explained by particular cell types, developmental epochs, or genetic constraints, highlighting the fact that the macroscopic network organization of the cerebral cortex is key to understanding the effects of gene dosage on cognitive traits.
Regulation of gene expression shapes the interaction between brain networks which in-turn supports psychological processes such as cognitive… (see more) ability. How changes in level of gene expression across the cerebral cortex influence cognitive ability remains unknown. Here, we tackle this by leveraging genomic deletions and duplications - copy number variants (CNVs) that fully encompass one or more genes expressed in the human cortex - which lead to large effects on gene-expression levels. We assigned genes to 180 regions of the human cerebral cortex based on their preferential expression across the cortex computed using data from the Allen Human Brain Atlas. We aggregated CNVs in cortical regions, and ran a burden association analysis to compute the mean effect size of genes on general cognitive ability for each of the 180 regions. When affected by CNVs, most of the regional gene-sets were associated with lower cognitive ability. The spatial patterns of effect sizes across the cortex were correlated negatively between deletions and duplications. The largest effect sizes for deletions and duplications were observed for gene-sets with high expression in sensorimotor and association regions, respectively. These two opposing patterns of effect sizes were not influenced by intolerance to loss of function, demonstrating orthogonality to dosage-sensitivity scores. The same mirror patterns were also observed after stratifying genes based on cell types and developmental epochs markers. These results suggest that the effect size of gene dosage on cognitive ability follows a cortical gradient. The same brain region and corresponding gene-set may show different effects on cognition depending on whether variants increase or decrease transcription. The latter has major implications for the association of brain networks with phenotypes
Regulation of gene expression shapes the interaction between brain networks which in-turn supports psychological processes such as cognitive… (see more) ability. How changes in level of gene expression across the cerebral cortex influence cognitive ability remains unknown. Here, we tackle this by leveraging genomic deletions and duplications - copy number variants (CNVs) that fully encompass one or more genes expressed in the human cortex - which lead to large effects on gene-expression levels. We assigned genes to 180 regions of the human cerebral cortex based on their preferential expression across the cortex computed using data from the Allen Human Brain Atlas. We aggregated CNVs in cortical regions, and ran a burden association analysis to compute the mean effect size of genes on general cognitive ability for each of the 180 regions. When affected by CNVs, most of the regional gene-sets were associated with lower cognitive ability. The spatial patterns of effect sizes across the cortex were correlated negatively between deletions and duplications. The largest effect sizes for deletions and duplications were observed for gene-sets with high expression in sensorimotor and association regions, respectively. These two opposing patterns of effect sizes were not influenced by intolerance to loss of function, demonstrating orthogonality to dosage-sensitivity scores. The same mirror patterns were also observed after stratifying genes based on cell types and developmental epochs markers. These results suggest that the effect size of gene dosage on cognitive ability follows a cortical gradient. The same brain region and corresponding gene-set may show different effects on cognition depending on whether variants increase or decrease transcription. The latter has major implications for the association of brain networks with phenotypes